Literature DB >> 20470301

Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome.

Akihiro Fukuda1, Shouichi Fujimoto, Shuji Iwatsubo, Hiroshi Kawachi, Kazuo Kitamura.   

Abstract

AIM: Several proteins constituting the slit diaphragm are considered important for maintaining capillary wall permselectivity. Early intervention with blockers of angiotensin II receptors (AR) and mineralocorticoid receptors (MR) is effective against proteinuria in models of chronic hypertensive and protein-induced renal damage. However, the effects of AR and/or MR blockers in a model of acute nephrotic syndrome remain unknown. The effects of AR and MR blockers were examined in puromycin aminonucleoside (PAN)-treated rats.
METHODS: Six week old male Sprague-Dawley (SD) rats were injected with PAN or vehicle and assigned to groups as follows: vehicle (group C); PAN (group P); PAN followed 3 days later by administration of the MR blocker, eplerenone (group MR), and by the AR blocker, losartan (group AR). Blood pressure and urinary protein excretion were measured and all rats were killed for immunohistochemical investigation on day 14 after PAN administration.
RESULTS: Blood pressure did not change throughout the study period. Proteinuria was decreased in groups MR and AR compared with group P (on day 14 after PAN administration, respectively; group P vs AR, P < 0.01; group P vs MR, P < 0.05). Nephrin, podocin and podocalyxin staining was preserved in the glomeruli of groups MR and AR compared with group P.
CONCLUSION: The MR and AR blockers decreased proteinuria in the acute model of nephrotic syndrome with preserved expression of glomerular podocyte protein independently of blood pressure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20470301     DOI: 10.1111/j.1440-1797.2009.01256.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  10 in total

Review 1.  Mineralocorticoid receptor activation as an etiological factor in kidney diseases.

Authors:  Kohei Ueda; Miki Nagase
Journal:  Clin Exp Nephrol       Date:  2013-07-06       Impact factor: 2.801

Review 2.  Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease.

Authors:  Miki Nagase; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2013-01-08       Impact factor: 28.314

3.  Angiotensin II type 1 receptor blockade ameliorates proteinuria in puromycin aminonucleoside nephropathy by inhibiting the reduction of NEPH1 and nephrin.

Authors:  Aya Takahashi; Yoshiyasu Fukusumi; Mihoko Yamazaki; Mutsumi Kayaba; Yukina Kitazawa; Masayuki Tomita; Hiroshi Kawachi
Journal:  J Nephrol       Date:  2014-10-09       Impact factor: 3.902

4.  Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli.

Authors:  Daria V Ilatovskaya; Oleg Palygin; Vladislav Levchenko; Alexander Staruschenko
Journal:  J Vis Exp       Date:  2015-06-27       Impact factor: 1.355

5.  Original Research: Potential of urinary nephrin as a biomarker reflecting podocyte dysfunction in various kidney disease models.

Authors:  Yusuke Wada; Masaki Abe; Hiroshi Moritani; Hikaru Mitori; Mitsuhiro Kondo; Keiko Tanaka-Amino; Megumi Eguchi; Akira Imasato; Yutaka Inoki; Hiroshi Kajiyama; Toshihide Mimura; Yuichi Tomura
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-22

Review 6.  The podocyte as a target for therapies--new and old.

Authors:  Peter W Mathieson
Journal:  Nat Rev Nephrol       Date:  2011-11-01       Impact factor: 28.314

7.  Relevance of VEGF and nephrin expression in glomerular diseases.

Authors:  Claudia A Bertuccio
Journal:  J Signal Transduct       Date:  2011-07-26

8.  Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease.

Authors:  Marc A Egerman; Jenny S Wong; Tian Runxia; Gohar Mosoyan; Kinsuk Chauhan; Joselyn Reyes-Bahamonde; Nanditha Anandakrishnan; Nicholas J Wong; Emilia Bagiella; Fadi Salem; Kristin Meliambro; Hong Li; Evren U Azeloglu; Steven G Coca; Kirk N Campbell; Leopoldo Raij
Journal:  FASEB J       Date:  2020-10-18       Impact factor: 5.834

Review 9.  New insight into podocyte slit diaphragm, a therapeutic target of proteinuria.

Authors:  Hiroshi Kawachi; Yoshiyasu Fukusumi
Journal:  Clin Exp Nephrol       Date:  2020-02-04       Impact factor: 2.801

10.  Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli.

Authors:  Daria V Ilatovskaya; Oleg Palygin; Vladislav Chubinskiy-Nadezhdin; Yuri A Negulyaev; Rong Ma; Lutz Birnbaumer; Alexander Staruschenko
Journal:  Kidney Int       Date:  2014-03-19       Impact factor: 10.612

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.